Editorial: Crosstalk Between Bone and Other Cells

Overview

Journal Front Physiol

Date 2023 May 25

PMID 37228815

Authors

Narattaphol Charoenphandhu

Krittikan Chanpaisaeng

Jarinthorn Teerapornpuntakit

Kannikar Wongdee

Affiliations

Soon will be listed here.

References

Liao C, Liang S, Wang Y, Zhong T, Liu X . Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry. J Transl Med. 2022; 20(1):221. PMC: 9102262. DOI: 10.1186/s12967-022-03417-4. View

Oniszczuk A, Kaczmarek A, Kaczmarek M, Cialowicz M, Arslan E, Silva A . Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review. Front Endocrinol (Lausanne). 2022; 13:954895. PMC: 9760825. DOI: 10.3389/fendo.2022.954895. View

Gomarasca M, Banfi G, Lombardi G . Myokines: The endocrine coupling of skeletal muscle and bone. Adv Clin Chem. 2020; 94:155-218. DOI: 10.1016/bs.acc.2019.07.010. View

Courbon G, Thomas J, Martinez-Calle M, Wang X, Spindler J, Von Drasek J . Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation. Blood. 2023; 142(1):106-118. PMC: 10356820. DOI: 10.1182/blood.2022018475. View

Wongdee K, Rodrat M, Keadsai C, Jantarajit W, Teerapornpuntakit J, Thongbunchoo J . Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)D-induced Ca transport: Evidence that explains how the intestine prevents excessive Ca absorption. Arch Biochem Biophys. 2018; 657:15-22. DOI: 10.1016/j.abb.2018.09.004. View

Weivoda M, Youssef S, Oursler M . Sclerostin expression and functions beyond the osteocyte. Bone. 2016; 96:45-50. PMC: 5328839. DOI: 10.1016/j.bone.2016.11.024. View

Huang H, Brennan T, Muir M, Mason R . Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. J Cell Physiol. 2009; 220(1):267-75. DOI: 10.1002/jcp.21761. View

Charoenphandhu N, Nakkrasae L, Kraidith K, Teerapornpuntakit J, Thongchote K, Thongon N . Two-step stimulation of intestinal Ca(2+) absorption during lactation by long-term prolactin exposure and suckling-induced prolactin surge. Am J Physiol Endocrinol Metab. 2009; 297(3):E609-19. DOI: 10.1152/ajpendo.00347.2009. View

van Bezooijen R, Roelen B, Visser A, van der Wee-Pals L, de Wilt E, Karperien M . Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med. 2004; 199(6):805-14. PMC: 2212719. DOI: 10.1084/jem.20031454. View

10.

Drake M, Khosla S . Hormonal and systemic regulation of sclerostin. Bone. 2016; 96:8-17. PMC: 5329134. DOI: 10.1016/j.bone.2016.12.004. View

11.

Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J . Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res. 2009; 24(10):1651-61. DOI: 10.1359/jbmr.090411. View

12.

Vervloet M . Renal and extrarenal effects of fibroblast growth factor 23. Nat Rev Nephrol. 2018; 15(2):109-120. DOI: 10.1038/s41581-018-0087-2. View

13.

Delgado-Calle J, Sato A, Bellido T . Role and mechanism of action of sclerostin in bone. Bone. 2016; 96:29-37. PMC: 5328835. DOI: 10.1016/j.bone.2016.10.007. View

14.

Perwad F, Zhang M, Tenenhouse H, Portale A . Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007; 293(5):F1577-83. DOI: 10.1152/ajprenal.00463.2006. View

15.

Bonnet N, Benhamou C, Malaval L, Goncalves C, Vico L, Eder V . Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol. 2008; 217(3):819-27. DOI: 10.1002/jcp.21564. View

16.

Bushinsky D, Krieger N . Effects of acid on bone. Kidney Int. 2022; 101(6):1160-1170. PMC: 9133222. DOI: 10.1016/j.kint.2022.02.032. View

17.

Brunkow M, Gardner J, Van Ness J, Paeper B, Kovacevich B, Proll S . Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet. 2001; 68(3):577-89. PMC: 1274471. DOI: 10.1086/318811. View

18.

Winkler D, Sutherland M, Geoghegan J, Yu C, Hayes T, Skonier J . Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003; 22(23):6267-76. PMC: 291840. DOI: 10.1093/emboj/cdg599. View

19.

Rousseaud A, Moriceau S, Ramos-Brossier M, Oury F . Bone-brain crosstalk and potential associated diseases. Horm Mol Biol Clin Investig. 2016; 28(2):69-83. DOI: 10.1515/hmbci-2016-0030. View

20.

Charoenphandhu N, Wongdee K, Tudpor K, Pandaranandaka J, Krishnamra N . Chronic metabolic acidosis upregulated claudin mRNA expression in the duodenal enterocytes of female rats. Life Sci. 2007; 80(19):1729-37. DOI: 10.1016/j.lfs.2007.01.063. View